PRP injections versus hyaluronic acid for advanced knee osteoarthritis
Official title: Efficacy of Therapy With Intra-articular Injections of PRP Compared With Therapy With Intra-articular Injections of HA, in Patients With Grade III or IV GONArthrosis: a Prospective Randomized Open-label Study
Run by Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer · NCT07016672 · Data updated 2026-11-12
This project will test whether platelet-rich plasma (PRP) injections or hyaluronic acid (HA) injections better reduce pain and improve function for people with moderate-to-severe knee osteoarthritis.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer Academic / other |
| Locations | 1 site (Toulon, Var) |
| Status | Recruiting |
| Started | September 18, 2025 |
| Main results expected | December 2027 |
| Study ends | October 2028 |
| Registry record updated | July 7, 2026 |
| Trial ID | NCT07016672 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults (≥18 years) with MRI-confirmed unilateral grade III or IV knee osteoarthritis, pain ≥3/10, BMI <35, able to give informed consent, and covered by social security.
✕Probably not a fit
Patients with early-stage OA, recent intra-articular PRP/HA/corticosteroid injections, uncontrolled medical conditions (including recent cancer), pregnancy or breastfeeding, anticoagulation that cannot be paused, or those under legal guardianship may not be eligible or likely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will run a randomized, open-label study comparing intra-articular PRP injections to hyaluronic acid (HA) injections in patients with MRI-confirmed grade III-IV knee osteoarthritis at Hôpital Sainte Musse in Toulon. Participants will be followed for 12 months after their last injection and outcomes will include pain (VAS), function (WOMAC), and quality of life (EQ-5D-5L). The trial uses standard-of-care injection procedures and validated questionnaires to measure changes over time. The aim is to determine which injection better reduces the functional impact of advanced gonarthrosis.
Why it matters
Potential benefit: If successful, the better-performing injection could reduce pain, improve daily function, and potentially delay the need for knee replacement surgery.
How similar studies have gone: Previous trials comparing PRP and HA have shown mixed results, with some reporting PRP offers greater short- to mid-term improvements in pain and function but evidence is inconsistent and less clear for advanced (grade III-IV) disease.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria:
1. Age ≥ 18 years ;
2. MRI confirmed grade III or IV unilateral gonarthrosis ;
3. Pain ≥ 3/10 on the visual analogue scale (VAS);
4. Patient with a BMI \< 35
5. Patient capable of giving consent prior to participation in the study;
6. Affiliated or entitled under a social security scheme.
Exclusion Criteria:
1. Non-steroidal anti-inflammatory drugs\* or corticosteroids\*\* taken in the 7 days prior to inclusion;
2. Local injection of hyaluronic acid in the 2 months prior to inclusion;
3. Local injection of PRP within 1 year prior to inclusion;
4. Local injection of corticosteroids within 5 months prior to inclusion;
5. Current anticoagulant treatment that cannot be stopped during the hyaluronic acid or PRP injection protocol period;
6. Patient diagnosed with any type of cancer in the last 3 years;
7. Pregnant women, women in labour or breast-feeding women;
8. Patients under judicial protection (guardianship, curatorship, etc.) or safeguard of justice;
9. Any other reason which, in the opinion of the investigator, could interfere with the evaluation of the study objectives.
* Acetylsalicylic acid is allowed when it is prescribed as an antiplatelet agent at doses lower than or equal to 160 mg per day. It has, indeed, no anti-inflammatory effect at these doses.
* Corticosteroids can be administered when they have a local action different from the one applied to the treated knee (cutaneous, instiled or inhaled routes).
Where it's running
-
Centre Hospitalier Intercommunal de Toulon- La Seyne sur Mer - Hôpital Sainte Musse
Toulon, Var, France Recruiting
Study contacts
- Study coordinator: Sophie Lafond
- Email: sophie.lafond@ch-toulon.fr
- Phone: 0483772062
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effects of virtual reality on walking in adults with knee osteoarthritis
This study tests how immersive virtual reality environments—designed to feel safe or to provoke fear—affect walking and worry about movement in adults 50 and older with knee osteoarthritis and in healthy peers.
-
Weekly berobenatide for knee osteoarthritis in adults who are overweight or obese
This study tests whether weekly berobenatide helps reduce knee pain and improve function, while also affecting body weight, in adults with knee osteoarthritis who are overweight or obese (with or without type 2 diabetes).
-
Autologous adipose-derived stem cell injections for knee osteoarthritis
We’re testing whether injecting a patient’s own fat-derived stem cells into the knee can help people with knee OA feel less pain and move better, compared with a standard hyaluronic acid treatment.
-
Preoperative Multimorbidity and Functional Recovery After Total Knee Arthroplasty
This study tests whether higher burden of preoperative multimorbidity affects functional recovery after knee replacement in adults with knee osteoarthritis.
-
Cartilage biomarker response to acute loading in knee OA by antiresorptive treatment status
Researchers will test whether a 30-minute treadmill walk changes cartilage biomarkers in postmenopausal women with knee osteoarthritis, comparing those on denosumab, bisphosphonates, and those not on antiresorptives.
-
Lysyl Enzymes in Knee Osteoarthritis
This study tests whether blood levels of lysyl hydroxylase and lysyl oxidase differ between people with knee osteoarthritis and healthy individuals.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.